rs1217691063
|
|
|
0.060 |
GeneticVariation |
BEFREE |
MTHFR C677T and A1298C polymorphisms were not associated with the presence of renal disease.
|
19376104 |
2009 |
rs1217691063
|
|
|
0.060 |
GeneticVariation |
BEFREE |
One putative determinant of PAD is the 677C>T polymorphism in the gene encoding methylenetetrahydrofolate reductase (MTHFR), which has previously been found to associate with various diabetic complications including retinopathy, nephropathy, atherosclerosis and coronary heart disease.
|
16274479 |
2005 |
rs1217691063
|
|
|
0.060 |
GeneticVariation |
BEFREE |
The relationship of the methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy.
|
17354258 |
2007 |
rs1217691063
|
|
|
0.060 |
GeneticVariation |
BEFREE |
The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus.
|
14737040 |
2004 |
rs1217691063
|
|
|
0.060 |
GeneticVariation |
BEFREE |
We analyzed 821 subjects with hypertensive nephrosclerosis from the longitudinal National Institute of Diabetes and Digestive and Kidney Diseases African-American Study of Kidney Disease and Hypertension (AASK) Trial to determine whether decline in glomerular filtration rate (GFR) over ∼4.2 years was predicted by common genetic variation within MTHFR at non-synonymous positions C677T (Ala222Val) and A1298C (Glu429Ala) or by MTHFR haplotypes.
|
21613384 |
2012 |
rs1217691063
|
|
|
0.060 |
GeneticVariation |
BEFREE |
The allele frequency of the C677T polymorphism in the MTHFR gene was 0.313 in the whole study population [wild-type (CC), 301; heterozygous (CT), 272; and homozygous mutant (TT), 63 patients, respectively] and showed no difference in the patient subgroups with various renal diseases.
|
10027946 |
1999 |
rs397507444
|
|
|
0.020 |
GeneticVariation |
BEFREE |
MTHFR C677T and A1298C polymorphisms were not associated with the presence of renal disease.
|
19376104 |
2009 |
rs397507444
|
|
|
0.020 |
GeneticVariation |
BEFREE |
We analyzed 821 subjects with hypertensive nephrosclerosis from the longitudinal National Institute of Diabetes and Digestive and Kidney Diseases African-American Study of Kidney Disease and Hypertension (AASK) Trial to determine whether decline in glomerular filtration rate (GFR) over ∼4.2 years was predicted by common genetic variation within MTHFR at non-synonymous positions C677T (Ala222Val) and A1298C (Glu429Ala) or by MTHFR haplotypes.
|
21613384 |
2012 |
rs1801131
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We analyzed 821 subjects with hypertensive nephrosclerosis from the longitudinal National Institute of Diabetes and Digestive and Kidney Diseases African-American Study of Kidney Disease and Hypertension (AASK) Trial to determine whether decline in glomerular filtration rate (GFR) over ∼4.2 years was predicted by common genetic variation within MTHFR at non-synonymous positions C677T (Ala222Val) and A1298C (Glu429Ala) or by MTHFR haplotypes.
|
21613384 |
2012 |
rs1801133
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We analyzed 821 subjects with hypertensive nephrosclerosis from the longitudinal National Institute of Diabetes and Digestive and Kidney Diseases African-American Study of Kidney Disease and Hypertension (AASK) Trial to determine whether decline in glomerular filtration rate (GFR) over ∼4.2 years was predicted by common genetic variation within MTHFR at non-synonymous positions C677T (Ala222Val) and A1298C (Glu429Ala) or by MTHFR haplotypes.
|
21613384 |
2012 |